Insider Trading History of Thorell Marella

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Thorell Marella since 2021. This trader's CIK number is 1826323. At the time of last reporting, Thorell Marella was the Chief Financial Officer of Evelo Biosciences, Inc.. (stock ticker symbol EVLO). Also see all insider trading activities at Evelo Biosciences, Inc..

Note that in the past Thorell Marella also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Evelo Biosciences, Inc. (EVLO) by Thorell Marella

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 EVLO 0 $0 46,345 $25,828 155,500 $0

Yearly summary of insider trading at Centessa Pharmaceuticals Plc (CNTA) by Thorell Marella

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 CNTA 1,000 $20,000 0 $0 0 $0


Insider trading activities at 2 companies by Thorell Marella:

1. Evelo Biosciences, Inc. (EVLO)

2. Centessa Pharmaceuticals Plc (CNTA)

Table 1. Insider trading of Evelo Biosciences, Inc. (EVLO) by Thorell Marella

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-11-08 EVLO Sale 1,811 .33 597
2023-11-07 EVLO Option Ex 6,500 .00 0
2023-11-02 EVLO Sale 3,999 .33 1,319
2023-11-01 EVLO Option Ex 12,500 .00 0
2023-08-08 EVLO Sale 2,004 9.51 19,058
2023-08-07 EVLO Option Ex 6,500 .00 0
2023-05-08 EVLO Sale 38,531 .13 4,854
2023-05-07 EVLO Option Ex 130,000 .00 0

Table 2. Insider trading of Centessa Pharmaceuticals Plc (CNTA) by Thorell Marella

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-06-02 CNTA Buy 1,000 20.00 20,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thorell Marella (Chief Financial Officer of Evelo Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.